Ra Pharmaceuticals to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference
December 07 2017 - 7:12AM
Business Wire
Ra Pharmaceuticals, Inc. (NASDAQ:RARX), a clinical stage
biopharmaceutical company focusing on the development of
next-generation therapeutics for the treatment of
complement-mediated diseases, today announced that Doug Treco,
Ph.D., President and Chief Executive Officer, will participate in a
fireside chat at the BMO Capital Markets Prescriptions for Success
Healthcare Conference on Thursday, December 14, 2017 at 3:30 p.m.
E.T. The conference is being held at the Westin New York Grand
Central Hotel.
A live webcast of the presentation can be accessed by visiting
the investor relations section of the Company’s
website, www.rapharma.com. A replay of the presentation will
also be available and archived on the site for three weeks.
About Ra Pharmaceuticals
Ra Pharmaceuticals is a clinical stage biopharmaceutical
company focusing on the development of next-generation therapeutics
for complement-mediated diseases. The Company discovers and
develops peptides and small molecules to target key components of
the complement cascade. For more information, please visit:
www.rapharma.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171207005396/en/
Ra Pharmaceuticals, Inc.Investors:Jennifer Robinson,
617-674-9873jrobinson@rapharma.comorMedia:Argot PartnersEliza
Schleifstein, 917-763-8106eliza@argotpartners.com
Ra Pharmaceuticals (NASDAQ:RARX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ra Pharmaceuticals (NASDAQ:RARX)
Historical Stock Chart
From Apr 2023 to Apr 2024